NO851877L - Nye terapeutisk virksomme pyrimidinforbindelser og fremgangsmaater til deres fremstilling. - Google Patents
Nye terapeutisk virksomme pyrimidinforbindelser og fremgangsmaater til deres fremstilling.Info
- Publication number
- NO851877L NO851877L NO851877A NO851877A NO851877L NO 851877 L NO851877 L NO 851877L NO 851877 A NO851877 A NO 851877A NO 851877 A NO851877 A NO 851877A NO 851877 L NO851877 L NO 851877L
- Authority
- NO
- Norway
- Prior art keywords
- amine
- methoxyphenyl
- methyl
- pyrimidin
- phenylpyrimidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848412184A GB8412184D0 (en) | 1984-05-12 | 1984-05-12 | Biologically active nitrogen heterocycles |
| GB858500417A GB8500417D0 (en) | 1985-01-08 | 1985-01-08 | Biologically active nitrogen heterocycles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO851877L true NO851877L (no) | 1985-11-13 |
Family
ID=26287736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO851877A NO851877L (no) | 1984-05-12 | 1985-05-10 | Nye terapeutisk virksomme pyrimidinforbindelser og fremgangsmaater til deres fremstilling. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0164204A1 (en, 2012) |
| AU (1) | AU4227685A (en, 2012) |
| DK (1) | DK203985A (en, 2012) |
| ES (1) | ES8609275A1 (en, 2012) |
| FI (1) | FI851837A7 (en, 2012) |
| GR (1) | GR851131B (en, 2012) |
| IL (1) | IL75147A0 (en, 2012) |
| NO (1) | NO851877L (en, 2012) |
| PT (1) | PT80432B (en, 2012) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4711888A (en) * | 1985-07-24 | 1987-12-08 | Pfizer Inc. | Hydroxy and alkoxy pyrimidines |
| EP0233461B2 (en) † | 1986-01-13 | 2002-05-29 | American Cyanamid Company | 4,5,6-Substituted-2-pyrimidinamines |
| GB8903592D0 (en) * | 1989-02-16 | 1989-04-05 | Boots Co Plc | Therapeutic agents |
| US5064963A (en) * | 1990-04-25 | 1991-11-12 | American Cyanamid Company | Process for the synthesis of n-(3-(1h-imidazol-1-yl)phenyl-4-(substituted)-2-pyrimidinamines |
| JPH06505239A (ja) * | 1991-01-31 | 1994-06-16 | ワーナー−ランバート・コンパニー | 抗炎症剤として有用な４，６−ジ−第三ブチル−５−ヒドロキシ−１，３−ピリミジンの置換されたヘテロアリール類似体 |
| US5177079A (en) * | 1991-01-31 | 1993-01-05 | Warner-Lambert Company | 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| US5248682A (en) * | 1991-01-31 | 1993-09-28 | Warner-Lambert Company | 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| US5270319A (en) * | 1991-09-09 | 1993-12-14 | Warner-Lambert Company | 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents |
| US5220025A (en) * | 1992-02-24 | 1993-06-15 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
| US5196431A (en) * | 1992-02-24 | 1993-03-23 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
| US5276186A (en) * | 1992-03-11 | 1994-01-04 | Ciba-Geigy Corporation | Process for the production of guanidine derivatives |
| US5521184A (en) * | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
| US5516775A (en) * | 1992-08-31 | 1996-05-14 | Ciba-Geigy Corporation | Further use of pyrimidine derivatives |
| CZ290681B6 (cs) * | 1993-10-01 | 2002-09-11 | Novartis Ag | N-Fenyl-2-pyrimidinaminové deriváty, způsob jejich výroby, farmaceutické prostředky, které je obsahují a jejich použití |
| US5543520A (en) * | 1993-10-01 | 1996-08-06 | Ciba-Geigy Corporation | Pyrimidine derivatives |
| WO1995009847A1 (en) * | 1993-10-01 | 1995-04-13 | Ciba-Geigy Ag | Pyrimidineamine derivatives and processes for the preparation thereof |
| WO1997033883A1 (en) * | 1996-03-13 | 1997-09-18 | Smithkline Beecham Corporation | Novel pyrimidine compounds useful in treating cytokine mediated diseases |
| US6184226B1 (en) | 1998-08-28 | 2001-02-06 | Scios Inc. | Quinazoline derivatives as inhibitors of P-38 α |
| EP1274705A1 (en) | 2000-03-29 | 2003-01-15 | Cyclacel Limited | 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders |
| PT1442024E (pt) * | 2001-11-01 | 2008-06-12 | Janssen Pharmaceutica Nv | Derivados aminobenzamida como inibidores da glicogénio sintase quinase 3$g(b) |
| PL369259A1 (en) | 2001-11-01 | 2005-04-18 | Janssen Pharmaceutica N.V. | Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) |
| TW200302728A (en) | 2002-02-01 | 2003-08-16 | Novartis Ag | Substituted amines as IgE inhibitors |
| AU2004261484A1 (en) | 2003-07-30 | 2005-02-10 | Cyclacel Limited | 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| CA2562244A1 (en) * | 2004-04-07 | 2005-10-27 | Takeda Pharmaceutical Company Limited | Cyclic compounds |
| CA2576159A1 (en) | 2004-08-27 | 2006-03-02 | Cyclacel Limited | Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases |
| RU2436776C2 (ru) | 2005-09-27 | 2011-12-20 | Айрм Ллк | ДИАРИЛАМИН-СОДЕРЖАЩИЕ СОЕДИНЕНИЯ, КОМПОЗИЦИИ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ МОДУЛЯТОРОВ РЕЦЕПТОРОВ с-КIT |
| GB0606774D0 (en) * | 2006-04-03 | 2006-05-10 | Novartis Ag | Organic compounds |
| MX2009011950A (es) | 2007-05-04 | 2009-12-11 | Irm Llc | Derivados de pirimidina y composiciones como inhibidores de cinasa c-kit y pdgfr. |
| EP2190836B1 (en) | 2007-08-22 | 2011-08-17 | Irm Llc | 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors |
| ES2477878T3 (es) * | 2007-08-22 | 2014-07-18 | Irm Llc | Compuestos y composiciones de 5-(4-(aloalcoxi)fenil)pirimidin-2-amina como inhibidores de quinasas |
| CA2724737A1 (en) * | 2008-05-19 | 2009-11-26 | The University Of Tennessee Research Foundation | Pyrimidine non-classical cannabinoid compounds and related methods of use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3496179A (en) * | 1967-10-11 | 1970-02-17 | Pfizer & Co C | 2-amino-3,4-dihydroquinazolines |
| US3635979A (en) * | 1969-09-29 | 1972-01-18 | Pfizer | Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines |
| CA961855A (en) * | 1969-10-16 | 1975-01-28 | Eli Lilly And Company | Immunosuppressants and anti-viral agents |
| US3900476A (en) * | 1973-05-17 | 1975-08-19 | Upjohn Co | 2(2'-pyrimidylamino)quinazolines and their preparation |
| US4010269A (en) * | 1975-06-16 | 1977-03-01 | The Upjohn Company | Antiviral quinazoline compositions and methods of use |
| DE3220118A1 (de) * | 1982-05-28 | 1983-12-01 | Bayer Ag, 5090 Leverkusen | Alkylenverbrueckte guanidinothiazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
-
1985
- 1985-04-25 EP EP85302902A patent/EP0164204A1/en not_active Withdrawn
- 1985-05-08 DK DK203985A patent/DK203985A/da not_active Application Discontinuation
- 1985-05-09 GR GR851131A patent/GR851131B/el unknown
- 1985-05-09 IL IL75147A patent/IL75147A0/xx unknown
- 1985-05-09 FI FI851837A patent/FI851837A7/fi not_active Application Discontinuation
- 1985-05-10 NO NO851877A patent/NO851877L/no unknown
- 1985-05-10 AU AU42276/85A patent/AU4227685A/en not_active Abandoned
- 1985-05-10 ES ES543047A patent/ES8609275A1/es not_active Expired
- 1985-05-10 PT PT80432A patent/PT80432B/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT80432B (en) | 1987-04-16 |
| ES8609275A1 (es) | 1986-07-16 |
| FI851837L (fi) | 1985-11-13 |
| AU4227685A (en) | 1985-11-14 |
| FI851837A0 (fi) | 1985-05-09 |
| GR851131B (en, 2012) | 1985-11-25 |
| DK203985D0 (da) | 1985-05-08 |
| PT80432A (en) | 1985-06-01 |
| EP0164204A1 (en) | 1985-12-11 |
| IL75147A0 (en) | 1985-09-29 |
| DK203985A (da) | 1985-11-13 |
| FI851837A7 (fi) | 1985-11-13 |
| ES543047A0 (es) | 1986-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO851877L (no) | Nye terapeutisk virksomme pyrimidinforbindelser og fremgangsmaater til deres fremstilling. | |
| US8592430B2 (en) | Quinazolin-oxime derivatives as Hsp90 inhibitors | |
| US5977118A (en) | 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones and compositions and methods of use thereof | |
| KR100626605B1 (ko) | 신규 피리다진 유도체 및 이를 유효성분으로 하는 의약 | |
| EP0055583B1 (en) | Antihypertensives | |
| AU7163196A (en) | Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions | |
| US7262202B2 (en) | Inhibitors of cyclin dependent kinases as anti-cancer agent | |
| US4515948A (en) | 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines | |
| CA2020370A1 (en) | Pyrimidine derivatives | |
| DK150142B (da) | Analogifremgangsmaade til fremstilling af 5-(2-imidazolin-2-yl)-aminopyrimidiner eller syreadditionssalte deraf | |
| HUP0203477A2 (hu) | Alkil-amino-helyettesített biciklikus nitrogén-heterociklusok mint P38 protein-kináz-inhibitorok, ezeket tartalmazó gyógyszerkészítmények és előállítási eljárásaik | |
| GB2087881A (en) | 5-substituted methyl-pyrimidine-2,4-diamines | |
| CA2031328A1 (en) | Xanthine derivatives, their production and use | |
| CZ297798A3 (cs) | Farmaceuticky vhodné isochinolinové deriváty a způsob jejich přípravy | |
| NO841168L (no) | Fremgangsmaate for fremstilling av pyrimidinderivater | |
| EP0077983B1 (en) | Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same | |
| ZA200100418B (en) | Aryl alkanoylpyridazines. | |
| EP0208518B1 (en) | 6-phenyl-pyridazinyl compounds | |
| CA2249420A1 (en) | 2-(3h)-oxazolone derivatives and their use as cox-2 inhibitors | |
| RU2328495C2 (ru) | Производное бензофурана | |
| PL210470B1 (pl) | Związki 4-imidazolin-2-onu i jego zastosowanie | |
| RU2116308C1 (ru) | Триазолпиримидиновые производные и фармацевтическая композиция | |
| US4666915A (en) | 2-anilino-1,6-dihydro-6-oxo-5-pyrimidine-carboxylic acid derivatives, process for the preparation thereof, and antiallergic agent containing the same | |
| US5698564A (en) | Diphenyl disulfide compounds | |
| CA2794952A1 (en) | Compounds and method for treatment of hiv |